GlaxoSmithKline(MX:GSK1N)
MX$468.000.00 (0.00%)
MX:GSK1N
GlaxoSmithKline earnings date
MX$468.00
At close:0.00 (0.00%)
GlaxoSmithKline (GSK1N) Q2 2026 Earnings Report
0 Followers
MX:GSK1N Q2 2026 EPS Results
- Actual EPS
- MXN 12.65
- Consensus EPS
- MXN 11.64
- Beat/Miss
- Beat by +MXN 1.00
- One Year Ago EPS
- MXN 11.64
MX:GSK1N Q2 2026 Revenue Results
- Actual Revenue
- MXN 210.57B
- Expected Revenue
- MXN 206.64B
- Beat/Miss
- Beat by +MXN 3.93B
- YoY Revenue Growth
- +5.30%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/28/2026
- Time
- Before Open
- Conference Call
- Tuesday, July 28, 2026
MX:GSK1N Upcoming Earnings
GlaxoSmithKline's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:GSK1N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 6.91- | 6.39 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | 12.6013.67 | 13.77 | -0.73% (-0.10) | |
| Jul 28, 2026 | 2026 (Q2) | 11.6412.65 | 11.64 | 8.60% (+1.00) | |
| Apr 29, 2026 | 2026 (Q1) | 10.7911.64 | 11.24 | 3.56% (+0.40) | |
| Feb 04, 2026 | 2025 (Q4) | 5.966.39 | 5.81 | 9.91% (+0.58) | |
| Oct 29, 2025 | 2025 (Q3) | 11.7713.77 | 12.45 | 10.66% (+1.33) | |
| Apr 30, 2025 | 2025 (Q1) | 10.0211.24 | 10.79 | 4.18% (+0.45) | |
| Feb 05, 2025 | 2024 (Q4) | 4.965.81 | 7.24 | -19.72% (-1.43) | |
| Oct 30, 2024 | 2024 (Q3) | 10.9912.45 | 12.62 | -1.39% (-0.18) | |
| Jul 31, 2024 | 2024 (Q2) | 9.5710.87 | 9.72 | 11.86% (+1.15) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

